🇺🇸 FDA
Company

COLLEGIUM

COLLEGIUM PHARMACEUTICAL, INC

COLL pharma USA

Quick answer

COLLEGIUM is a pharma company (COLL) headquartered in STOUGHTON, MA, USA with 21 tracked pipeline programs.

Pipeline (21)

project

De-escalation to ticagrelor 60 mg at day 30

Non ST Segment Elevation Acute Coronary Syndrome

Phase 3 · small_molecule · active

1 trials project

Empagliflozin 10 MG

Acute Decompensated Heart Failure

Phase 3 · small_molecule · active

1 trials project

Empagliflozin 20 mg

Metabolic Syndrome

Phase 3 · small_molecule · active

1 trials project

Evolocumab

Sars-CoV-2 Infection

Phase 3 · small_molecule · completed

1 trials project

HLD200 methylphenidate hydrochloride capsules

Attention Deficit Hyperactivity Disorder

Phase 3 · small_molecule · terminated

1 trials project

Methoxyflurane - Penthrox

ST Elevation Myocardial Infarction

Phase 3 · small_molecule · active

1 trials project

Oxycodone DETERx

Chronic Low Back Pain

Phase 3 · small_molecule · completed

1 trials project

Ticagrelor 90 mg

Myocardial Infarction

Phase 3 · small_molecule · completed

1 trials project

Ticagrelor 90mg

STEMI

Phase 3 · small_molecule · active

1 trials project

Crushed ticagrelor followed by morphine

Unstable Angina Pectoris

Approved · small_molecule · completed

2 trials project

Levosimendan

Systolic Heart Failure

Approved · small_molecule · active

1 trials project

Morphine

ST-segment Elevation Myocardial Infarction

Approved · small_molecule · completed

1 trials project

Pulverized ticagrelor sublingually

Unstable Angina Pectoris

Approved · small_molecule · completed

1 trials project

Rifaximin

ACS - Acute Coronary Syndrome

Approved · small_molecule · active

1 trials project

Rosuvastatin and Ezetimibe morning or evening administration

Hypercholesterolemia

Approved · small_molecule · completed

1 trials project

Ticagrelor followed with Methoxyflurane

Unstable Angina

Approved · small_molecule · completed

1 trials project

Xtampza ER (oxycodone)

Chronic Pain

Approved · small_molecule · terminated

1 trials project

Gold omega 3

Chronic Kidney Disease

Unknown · other · active

1 trials project

Immunological Factors

Neuropathic Pain

Unknown · other · active

1 trials project

Oral Chondroitin Sulfate (Flextrum)

Meniscus Lesion

Unknown · other · completed

1 trials project

Platelet-rich plasma

ACL Injury

Unknown · mab · active

1 trials

Drugs (2)

drug

oxycodone

XTAMPZA ER

 drug

tapentadol hydrochloride

TAPENTADOL HYDROCHLORIDE

Patents (8)

patent

US 11191758

Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of

Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10668060

Tamper-resistant pharmaceutical compositions of opioids and other drugs

Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10646485

Process of making stable abuse-deterrent oral formulations

Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10525052

Abuse-deterrent drug formulations

Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10525053

Abuse-deterrent pharmaceutical compositions of opioids and other drugs

Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10188644

Process of making stable abuse-deterrent oral formulations

Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10004729

Tamper-resistant pharmaceutical compositions of opioids and other drugs

Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9968598

Process of making stable abuse-deterrent oral formulations

Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)